Seres Therapeutics Ownership 2024 | Who Owns Seres Therapeutics Now?
Institutional Ownership
47.27%
Insider Ownership
13.20%
Retail Ownership
39.53%
Institutional Holders
93.00
Seres Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 15.82% | 1.98% | 23,117,045 | - | - | 16,732,118 | Jun 30, 2024 |
| FMR LLC | 15.55% | 0.00% | 22,717,164 | 65,745 | 0.29% | 16,442,683 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.30% | 0.00% | 6,285,749 | -449,072 | -6.67% | 4,549,625 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.65% | 0.18% | 2,407,112 | 1,500,000 | 165.36% | 1,742,268 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.22% | 0.00% | 1,777,601 | 750,049 | 72.99% | 1,286,628 | Jun 30, 2024 |
| BLACKROCK INC. | 1.21% | - | 1,762,157 | -5,063,242 | -74.18% | 1,275,449 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.78% | 0.00% | 1,133,625 | -999,018 | -46.84% | 820,704 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.69% | 0.00% | 1,004,978 | -4,420,022 | -81.48% | 727,403 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.49% | 0.00% | 721,758 | -62,935 | -8.02% | 522,409,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.46% | 0.00% | 666,951 | -397,186 | -37.32% | 482,739 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.36% | 0.00% | 525,947 | -221,371 | -29.62% | 380,680 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.29% | 0.02% | 418,208 | -970,736 | -69.89% | 302,699 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.23% | 0.45% | 340,761 | - | - | 246,643 | Jun 30, 2024 |
| STATE STREET CORP | 0.23% | - | 339,548 | -1,606,815 | -82.55% | 245,765,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.21% | 0.00% | 314,177 | 314,177 | 100.00% | 227,401 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.20% | 0.06% | 292,300 | - | - | 211,567 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.18% | - | 267,398 | -30,713 | -10.30% | 194,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.14% | - | 200,726 | 94,760 | 89.42% | 145,325 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.13% | 0.00% | 187,800 | 187,800 | 100.00% | 135,930 | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | - | 171,086 | -306,539 | -64.18% | 123,832 | Jun 30, 2024 |
Seres Therapeutics's largest institutional shareholder is FLAGSHIP PIONEERING INC., holding 15.82% of the company's total share outstanding, currently valued at $16.73M. The top 10 institutional shareholders own together 42.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 15.82% | 1.98% | 23,117,045 | - | - | 16,732,118 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.23% | 0.45% | 340,761 | - | - | 246,643 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.65% | 0.18% | 2,407,112 | 1,500,000 | 165.36% | 1,742,268 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.20% | 0.06% | 292,300 | - | - | 211,567 | Jun 30, 2024 |
| PROVIDENCE WEALTH ADVISORS, LLC | 0.05% | 0.05% | 76,250 | 25,250 | 49.51% | 57,950 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.29% | 0.02% | 418,208 | -970,736 | -69.89% | 302,699 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.02% | 127,634 | 127,634 | 100.00% | 92,382 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 0.03% | 0.02% | 49,363 | - | - | 35,729 | Jun 30, 2024 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 0.03% | 0.02% | 43,298 | -1,994 | -4.40% | 31,339 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.08% | 0.00% | 123,590 | 123,590 | 100.00% | 89,454 | Jun 30, 2024 |
| AUOUR INVESTMENTS LLC | 0.01% | 0.00% | 17,000 | - | - | 12,305 | Jun 30, 2024 |
| ARIES WEALTH MANAGEMENT | 0.01% | 0.00% | 17,000 | 5,000 | 41.67% | 12,305 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.69% | 0.00% | 1,004,978 | -4,420,022 | -81.48% | 727,403 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.13% | 0.00% | 187,800 | 187,800 | 100.00% | 135,930 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.06% | 0.00% | 87,754 | 87,754 | 100.00% | 63,516 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.08% | 0.00% | 111,032 | 111,032 | 100.00% | 80,365 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.03% | 0.00% | 40,600 | -53,910 | -57.04% | 29,000 | Jun 30, 2024 |
| CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 0.01% | 0.00% | 19,200 | -4,250 | -18.12% | 13,897 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.06% | 0.00% | 89,962 | 77,311 | 611.11% | 65,115 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.00% | 22,132 | -53,560 | -70.76% | 16,019 | Jun 30, 2024 |
The largest Seres Therapeutics shareholder by % of total assets is FLAGSHIP PIONEERING INC.. The company owns 23.12M shares of Seres Therapeutics (MCRB), representing 1.98% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1.65% | 0.18% | 2,407,112 | 1,500,000 | 165.36% | 1,742,268 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.22% | 0.00% | 1,777,601 | 750,049 | 72.99% | 1,286,628 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.21% | 0.00% | 314,177 | 314,177 | 100.00% | 227,401 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.13% | 0.00% | 187,800 | 187,800 | 100.00% | 135,930 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.02% | 127,634 | 127,634 | 100.00% | 92,382 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.08% | 0.00% | 123,590 | 123,590 | 100.00% | 89,454 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.08% | 0.00% | 111,032 | 111,032 | 100.00% | 80,365 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.07% | 0.00% | 94,972 | 94,972 | 100.00% | 68,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.14% | - | 200,726 | 94,760 | 89.42% | 145,325 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.06% | 0.00% | 87,754 | 87,754 | 100.00% | 63,516 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.06% | 0.00% | 89,962 | 77,311 | 611.11% | 65,115 | Jun 30, 2024 |
| FMR LLC | 15.55% | 0.00% | 22,717,164 | 65,745 | 0.29% | 16,442,683 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.04% | 0.00% | 60,100 | 60,100 | 100.00% | 43,500 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.08% | 0.00% | 111,251 | 52,475 | 89.28% | 80,523,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 50,437 | 50,437 | 100.00% | 36,506 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.04% | 0.00% | 55,000 | 40,000 | 266.67% | 40,000 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.02% | 0.00% | 26,522 | 26,522 | 100.00% | 19,197 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.03% | 0.00% | 48,070 | 25,325 | 111.34% | 34,793 | Jun 30, 2024 |
| PROVIDENCE WEALTH ADVISORS, LLC | 0.05% | 0.05% | 76,250 | 25,250 | 49.51% | 57,950 | Jun 30, 2024 |
| EVERCORE WEALTH MANAGEMENT, LLC | 0.02% | 0.00% | 25,000 | 25,000 | 100.00% | 18,095 | Jun 30, 2024 |
As of Jun 30 2024, Seres Therapeutics's largest institutional buyer is TANG CAPITAL MANAGEMENT LLC. The company purchased 1.50M stocks of MCRB, valued at $1.74M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.21% | - | 1,762,157 | -5,063,242 | -74.18% | 1,275,449 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.69% | 0.00% | 1,004,978 | -4,420,022 | -81.48% | 727,403 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -2,045,871 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 0.23% | - | 339,548 | -1,606,815 | -82.55% | 245,765,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.07% | - | 105,041 | -1,549,921 | -93.65% | 75,944 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | - | - | - | -1,100,000 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.78% | 0.00% | 1,133,625 | -999,018 | -46.84% | 820,704 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.29% | 0.02% | 418,208 | -970,736 | -69.89% | 302,699 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -486,353 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.30% | 0.00% | 6,285,749 | -449,072 | -6.67% | 4,549,625 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.46% | 0.00% | 666,951 | -397,186 | -37.32% | 482,739 | Jun 30, 2024 |
| SIT INVESTMENT ASSOCIATES INC | - | - | - | -342,200 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -329,072 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -309,379 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | - | 171,086 | -306,539 | -64.18% | 123,832 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.36% | 0.00% | 525,947 | -221,371 | -29.62% | 380,680 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -166,887 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -127,660 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -103,316 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Seres Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -5.06M shares of MCRB, valued at $1.28M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERITION FUND MANAGEMENT LLC | 0.21% | 0.00% | 314,177 | 314,177 | 100.00% | 227,401 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.13% | 0.00% | 187,800 | 187,800 | 100.00% | 135,930 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.08% | 0.00% | 111,032 | 111,032 | 100.00% | 80,365 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.06% | 0.00% | 87,754 | 87,754 | 100.00% | 63,516 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.04% | 0.00% | 60,100 | 60,100 | 100.00% | 43,500 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 50,437 | 50,437 | 100.00% | 36,506 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.02% | 0.00% | 26,522 | 26,522 | 100.00% | 19,197 | Jun 30, 2024 |
| EVERCORE WEALTH MANAGEMENT, LLC | 0.02% | 0.00% | 25,000 | 25,000 | 100.00% | 18,095 | Jun 30, 2024 |
| AVANTAX ADVISORY SERVICES, INC. | 0.01% | 0.00% | 16,679 | 16,679 | 100.00% | 12,072 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.01% | 0.00% | 10,236 | 10,236 | 100.00% | 7,409 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 4,945 | 4,945 | 100.00% | 3,579 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 666 | 666 | 100.00% | 892 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 611 | 611 | 100.00% | 442 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.00% | - | 200 | 200 | 100.00% | 145 | Jun 30, 2024 |
| WHITTIER TRUST CO | - | - | 30 | 30 | 100.00% | 21 | Jun 30, 2024 |
Seres Therapeutics's largest new institutional shareholder by number of shares is VERITION FUND MANAGEMENT LLC, purchased 314.18K shares, valued at $227.40K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -2,045,871 | -100.00% | - | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | - | - | - | -1,100,000 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -486,353 | -100.00% | - | Jun 30, 2024 |
| SIT INVESTMENT ASSOCIATES INC | - | - | - | -342,200 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -329,072 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -309,379 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -166,887 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -127,660 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -103,316 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -70,598 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -50,102 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -48,475 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -33,061 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -29,008 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -17,000 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -14,600 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -10,376 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -9,985 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -9,888 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -8,033 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -6,203 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -2,396 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -1,600 | -100.00% | - | Jun 30, 2024 |
| ORION CAPITAL MANAGEMENT LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -20 | -100.00% | - | Jun 30, 2024 |
Seres Therapeutics's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -2.05M shares, valued at -, as of undefined.
Seres Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.99% | 918,847 | - | - | Jan 31, 2024 |
| Ark ETF Trust | 0.77% | 6,170,699 | - | - | Jan 31, 2024 |
| SIT MUTUAL FUNDS INC | 0.67% | 246,775 | - | - | Mar 28, 2024 |
| Vanguard Montgomery Funds | 0.37% | 88,955 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.33% | 9,564,601 | -196,794 | -2.02% | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.31% | 6,013,122 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.18% | 368,214 | - | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.14% | 471,039 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.13% | 69,975 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.13% | 348,666 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.10% | 1,222,006 | 947,446 | 345.08% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.08% | 1,678 | - | - | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.07% | 168,609 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 150,000 | 85,000 | 130.77% | Mar 28, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.06% | 262,452 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.05% | 225,434 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.05% | 11,900 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.04% | 8,435 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.03% | 75,220 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.03% | 330,500 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 168,991 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 15,065 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.02% | 405,600 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 73,068 | - | - | Jan 31, 2024 |
| FORUM FUNDS II | 0.02% | 18,400 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 45,536 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 854,347 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 29,980 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 20,835 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 16,156 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,420,970 | -1,268,030 | -22.29% | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.01% | 245,788 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 550,626 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,061 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.01% | 30,844 | - | - | Mar 28, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 45,431 | - | - | Aug 31, 2023 |
| ALPS ETF Trust | 0.01% | 78,420 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 225,395 | -40,525 | -15.24% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 735,225 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 909,509 | -77,142 | -7.82% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 313,062 | - | - | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 967,347 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.00% | 15,915 | - | - | Mar 28, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 98,507 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 8,033 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 11,963 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 50,972 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 106,883 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 61,360 | -4,692 | -7.10% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 289,268 | -332 | -0.11% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 353,709 | 1,776 | 0.50% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 10,900 | - | - | Mar 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 58,329 | - | - | Mar 28, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 14,929 | -34,242 | -69.64% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,387 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 455 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 33,061 | -7,471 | -18.43% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 775 | - | - | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 16,907 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 438 | - | - | Apr 30, 2021 |
| SCHWAB STRATEGIC TRUST | 0.00% | 465,665 | -31,688 | -6.37% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,730 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 6,209 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 2,564 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 30,746 | - | - | Mar 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 26,936 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 4,750 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 5,523 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 307,481 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 254,275 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,366 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 998 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 33,558 | -10,065 | -23.07% | Mar 28, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 438,965 | 56,482 | 14.77% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 887 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 3,474,631 | -370,983 | -9.65% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 7,515,914 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,453 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 9,441 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 17,446 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 4,132 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 37,331 | -150 | -0.40% | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 5,812 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,600 | - | - | Mar 28, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 52,886 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 14,647 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 440 | - | - | Dec 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 34,027 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 31,856 | 20,099 | 170.95% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 7,977 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,852 | -91 | -0.83% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 237,704 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 23,360 | - | - | Jan 31, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 288,596 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 414 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 763 | -56 | -6.84% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 14,253 | -6,495 | -31.30% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 6,140 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 13,038 | 2,471 | 23.38% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 4,888 | - | - | Mar 31, 2024 |
Seres Therapeutics's largest mutual fund holder by % of total assets is "LORD ABBETT DEVELOPING GROWTH FUND, INC.", owning 918.85K shares, compromising 0.99% of its total assets.
Seres Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 93 | -7.92% |
| 31 Mar, 24 | 101 | -9.82% |
| 31 Dec, 23 | 112 | -23.81% |
| 30 Sep, 23 | 147 | -2.65% |
| 30 Jun, 23 | 151 | 13.53% |
| 31 Mar, 23 | 133 | - |
| 31 Dec, 22 | 133 | 8.13% |
| 30 Sep, 22 | 123 | -4.65% |
| 30 Jun, 22 | 129 | -6.52% |
| 31 Mar, 22 | 138 | -13.21% |
| 31 Dec, 21 | 159 | 8.90% |
| 30 Sep, 21 | 146 | -10.98% |
| 30 Jun, 21 | 164 | -1.80% |
| 31 Mar, 21 | 167 | 5.03% |
| 31 Dec, 20 | 159 | 20.45% |
| 30 Sep, 20 | 132 | 32.00% |
| 30 Jun, 20 | 100 | 33.33% |
| 31 Mar, 20 | 75 | -5.06% |
| 31 Dec, 19 | 79 | - |
| 30 Sep, 19 | 79 | -12.22% |
| 30 Jun, 19 | 90 | 9.76% |
| 31 Mar, 19 | 82 | 18.84% |
| 31 Dec, 18 | 69 | -4.17% |
| 30 Sep, 18 | 72 | -8.86% |
| 30 Jun, 18 | 79 | -3.66% |
| 31 Mar, 18 | 82 | -6.82% |
| 31 Dec, 17 | 88 | 1.15% |
| 30 Sep, 17 | 87 | 12.99% |
| 30 Jun, 17 | 77 | -7.23% |
| 31 Mar, 17 | 83 | -10.75% |
| 31 Dec, 16 | 93 | -8.82% |
| 30 Sep, 16 | 102 | 6.25% |
| 30 Jun, 16 | 96 | 18.52% |
| 31 Mar, 16 | 81 | 9.46% |
| 31 Dec, 15 | 74 | 21.31% |
| 30 Sep, 15 | 61 | 35.56% |
| 30 Jun, 15 | 45 | - |
As of 30 Jun 24, 93 institutions are holding Seres Therapeutics's shares, representing a decrease of -7.92% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 69,063,033 | -19.39% |
| 31 Mar, 24 | 85,680,215 | -4.29% |
| 31 Dec, 23 | 89,517,414 | -16.63% |
| 30 Sep, 23 | 107,377,449 | -4.75% |
| 30 Jun, 23 | 112,729,757 | 7.62% |
| 31 Mar, 23 | 104,749,458 | -0.31% |
| 31 Dec, 22 | 105,075,273 | 0.38% |
| 30 Sep, 22 | 104,678,994 | 18.73% |
| 30 Jun, 22 | 88,166,227 | 16.93% |
| 31 Mar, 22 | 75,401,662 | -2.29% |
| 31 Dec, 21 | 77,167,583 | -3.04% |
| 30 Sep, 21 | 79,586,483 | -7.86% |
| 30 Jun, 21 | 86,371,489 | -4.01% |
| 31 Mar, 21 | 89,975,085 | 4.02% |
| 31 Dec, 20 | 86,497,174 | 0.49% |
| 30 Sep, 20 | 86,071,232 | 19.60% |
| 30 Jun, 20 | 71,965,399 | 6.16% |
| 31 Mar, 20 | 67,790,841 | 2.81% |
| 31 Dec, 19 | 65,938,019 | 2.52% |
| 30 Sep, 19 | 64,315,367 | 4.94% |
| 30 Jun, 19 | 61,288,006 | 81.83% |
| 31 Mar, 19 | 33,706,180 | 6.31% |
| 31 Dec, 18 | 31,706,482 | -0.97% |
| 30 Sep, 18 | 32,016,953 | 0.54% |
| 30 Jun, 18 | 31,844,672 | -1.54% |
| 31 Mar, 18 | 32,343,677 | 0.72% |
| 31 Dec, 17 | 32,112,520 | 4.34% |
| 30 Sep, 17 | 30,777,746 | 1.93% |
| 30 Jun, 17 | 30,193,964 | -1.04% |
| 31 Mar, 17 | 30,512,593 | -1.92% |
| 31 Dec, 16 | 31,110,411 | -0.20% |
| 30 Sep, 16 | 31,171,920 | -1.11% |
| 30 Jun, 16 | 31,522,082 | 1.86% |
| 31 Mar, 16 | 30,947,154 | 5.67% |
| 31 Dec, 15 | 29,286,762 | 112.05% |
| 30 Sep, 15 | 13,811,499 | 21.35% |
| 30 Jun, 15 | 11,381,595 | - |
Seres Therapeutics (MCRB) has 69.06M shares outstanding as of 30 Jun 24, down -19.39% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 47.27% | 1.06% |
| 31 Mar, 24 | 66.94% | 1.37% |
| 31 Dec, 23 | 69.78% | 0.99% |
| 30 Sep, 23 | 84.08% | 1.05% |
| 30 Jun, 23 | 89.57% | 1.29% |
| 31 Mar, 23 | 83.22% | 0.88% |
| 31 Dec, 22 | 97.22% | 1.33% |
| 30 Sep, 22 | 85.43% | 0.94% |
| 30 Jun, 22 | 95.57% | 1.43% |
| 31 Mar, 22 | 81.81% | 1.16% |
| 31 Dec, 21 | 84.10% | 1.12% |
| 30 Sep, 21 | 86.74% | 0.98% |
| 30 Jun, 21 | 94.23% | 0.98% |
| 31 Mar, 21 | 98.30% | 0.84% |
| 31 Dec, 20 | 108.41% | 1.02% |
| 30 Sep, 20 | 103.04% | 1.07% |
| 30 Jun, 20 | 98.17% | 1.07% |
| 31 Mar, 20 | 95.72% | 1.10% |
| 31 Dec, 19 | 93.10% | 1.10% |
| 30 Sep, 19 | 91.95% | 0.50% |
| 30 Jun, 19 | 135.77% | 2.01% |
| 31 Mar, 19 | 82.15% | 1.38% |
| 31 Dec, 18 | 77.28% | 1.26% |
| 30 Sep, 18 | 78.46% | 1.28% |
| 30 Jun, 18 | 78.32% | 1.24% |
| 31 Mar, 18 | 79.61% | 1.27% |
| 31 Dec, 17 | 79.04% | 1.37% |
| 30 Sep, 17 | 76.01% | 1.36% |
| 30 Jun, 17 | 74.75% | 1.31% |
| 31 Mar, 17 | 75.59% | 1.27% |
| 31 Dec, 16 | 77.07% | 1.28% |
| 30 Sep, 16 | 77.47% | 1.22% |
| 30 Jun, 16 | 79.60% | 1.28% |
| 31 Mar, 16 | 78.97% | 1.41% |
| 31 Dec, 15 | 74.74% | 6.02% |
| 30 Sep, 15 | 35.25% | 4.18% |
| 30 Jun, 15 | 29.05% | - |
As of 30 Jun 24, Seres Therapeutics is held by 47.27% institutional shareholders, representing a 1.06% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 45 | -4.26% |
| 31 Mar, 24 | 47 | 6.82% |
| 31 Dec, 23 | 44 | -40.54% |
| 30 Sep, 23 | 74 | -22.92% |
| 30 Jun, 23 | 96 | 52.38% |
| 31 Mar, 23 | 63 | -1.56% |
| 31 Dec, 22 | 64 | -12.33% |
| 30 Sep, 22 | 73 | 37.74% |
| 30 Jun, 22 | 53 | 1.92% |
| 31 Mar, 22 | 52 | -39.53% |
| 31 Dec, 21 | 86 | 10.26% |
| 30 Sep, 21 | 78 | -6.02% |
| 30 Jun, 21 | 83 | -6.74% |
| 31 Mar, 21 | 89 | -13.59% |
| 31 Dec, 20 | 103 | 24.10% |
| 30 Sep, 20 | 83 | 23.88% |
| 30 Jun, 20 | 67 | 76.32% |
| 31 Mar, 20 | 38 | -20.83% |
| 31 Dec, 19 | 48 | 11.63% |
| 30 Sep, 19 | 43 | -24.56% |
| 30 Jun, 19 | 57 | 21.28% |
| 31 Mar, 19 | 47 | 88.00% |
| 31 Dec, 18 | 25 | -19.35% |
| 30 Sep, 18 | 31 | -6.06% |
| 30 Jun, 18 | 33 | - |
| 31 Mar, 18 | 33 | -23.26% |
| 31 Dec, 17 | 43 | -6.52% |
| 30 Sep, 17 | 46 | 21.05% |
| 30 Jun, 17 | 38 | - |
| 31 Mar, 17 | 38 | -19.15% |
| 31 Dec, 16 | 47 | -22.95% |
| 30 Sep, 16 | 61 | -11.59% |
| 30 Jun, 16 | 69 | 50.00% |
| 31 Mar, 16 | 46 | -8.00% |
| 31 Dec, 15 | 50 | 13.64% |
| 30 Sep, 15 | 44 | -2.22% |
| 30 Jun, 15 | 45 | - |
45 institutional shareholders have increased their position in MCRB stock as of 30 Jun 24 compared to 47 in the previous quarter (a -4.26% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 26 | -7.14% |
| 31 Mar, 24 | 28 | -33.33% |
| 31 Dec, 23 | 42 | 31.25% |
| 30 Sep, 23 | 32 | 23.08% |
| 30 Jun, 23 | 26 | -29.73% |
| 31 Mar, 23 | 37 | 2.78% |
| 31 Dec, 22 | 36 | 38.46% |
| 30 Sep, 22 | 26 | -45.83% |
| 30 Jun, 22 | 48 | -12.73% |
| 31 Mar, 22 | 55 | 25.00% |
| 31 Dec, 21 | 44 | 33.33% |
| 30 Sep, 21 | 33 | -26.67% |
| 30 Jun, 21 | 45 | -4.26% |
| 31 Mar, 21 | 47 | 23.68% |
| 31 Dec, 20 | 38 | 22.58% |
| 30 Sep, 20 | 31 | 106.67% |
| 30 Jun, 20 | 15 | -34.78% |
| 31 Mar, 20 | 23 | 43.75% |
| 31 Dec, 19 | 16 | -11.11% |
| 30 Sep, 19 | 18 | 38.46% |
| 30 Jun, 19 | 13 | -13.33% |
| 31 Mar, 19 | 15 | -46.43% |
| 31 Dec, 18 | 28 | 64.71% |
| 30 Sep, 18 | 17 | -26.09% |
| 30 Jun, 18 | 23 | -23.33% |
| 31 Mar, 18 | 30 | 25.00% |
| 31 Dec, 17 | 24 | 50.00% |
| 30 Sep, 17 | 16 | -27.27% |
| 30 Jun, 17 | 22 | -15.38% |
| 31 Mar, 17 | 26 | 30.00% |
| 31 Dec, 16 | 20 | 11.11% |
| 30 Sep, 16 | 18 | 28.57% |
| 30 Jun, 16 | 14 | -6.67% |
| 31 Mar, 16 | 15 | 15.38% |
| 31 Dec, 15 | 13 | 85.71% |
| 30 Sep, 15 | 7 | - |
| 30 Jun, 15 | - | - |
26 institutional shareholders have reduced their position in MCRB stock as of 30 Jun 24 compared to 28 in the previous quarter (a -7.14% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 93 | -7.92% | 69,063,033 | -19.39% | 47.27% | 1.06% | 45 | -4.26% | 26 | -7.14% |
| 31 Mar, 24 | 101 | -9.82% | 85,680,215 | -4.29% | 66.94% | 1.37% | 47 | 6.82% | 28 | -33.33% |
| 31 Dec, 23 | 112 | -23.81% | 89,517,414 | -16.63% | 69.78% | 0.99% | 44 | -40.54% | 42 | 31.25% |
| 30 Sep, 23 | 147 | -2.65% | 107,377,449 | -4.75% | 84.08% | 1.05% | 74 | -22.92% | 32 | 23.08% |
| 30 Jun, 23 | 151 | 13.53% | 112,729,757 | 7.62% | 89.57% | 1.29% | 96 | 52.38% | 26 | -29.73% |
| 31 Mar, 23 | 133 | - | 104,749,458 | -0.31% | 83.22% | 0.88% | 63 | -1.56% | 37 | 2.78% |
| 31 Dec, 22 | 133 | 8.13% | 105,075,273 | 0.38% | 97.22% | 1.33% | 64 | -12.33% | 36 | 38.46% |
| 30 Sep, 22 | 123 | -4.65% | 104,678,994 | 18.73% | 85.43% | 0.94% | 73 | 37.74% | 26 | -45.83% |
| 30 Jun, 22 | 129 | -6.52% | 88,166,227 | 16.93% | 95.57% | 1.43% | 53 | 1.92% | 48 | -12.73% |
| 31 Mar, 22 | 138 | -13.21% | 75,401,662 | -2.29% | 81.81% | 1.16% | 52 | -39.53% | 55 | 25.00% |
| 31 Dec, 21 | 159 | 8.90% | 77,167,583 | -3.04% | 84.10% | 1.12% | 86 | 10.26% | 44 | 33.33% |
| 30 Sep, 21 | 146 | -10.98% | 79,586,483 | -7.86% | 86.74% | 0.98% | 78 | -6.02% | 33 | -26.67% |
| 30 Jun, 21 | 164 | -1.80% | 86,371,489 | -4.01% | 94.23% | 0.98% | 83 | -6.74% | 45 | -4.26% |
| 31 Mar, 21 | 167 | 5.03% | 89,975,085 | 4.02% | 98.30% | 0.84% | 89 | -13.59% | 47 | 23.68% |
| 31 Dec, 20 | 159 | 20.45% | 86,497,174 | 0.49% | 108.41% | 1.02% | 103 | 24.10% | 38 | 22.58% |
| 30 Sep, 20 | 132 | 32.00% | 86,071,232 | 19.60% | 103.04% | 1.07% | 83 | 23.88% | 31 | 106.67% |
| 30 Jun, 20 | 100 | 33.33% | 71,965,399 | 6.16% | 98.17% | 1.07% | 67 | 76.32% | 15 | -34.78% |
| 31 Mar, 20 | 75 | -5.06% | 67,790,841 | 2.81% | 95.72% | 1.10% | 38 | -20.83% | 23 | 43.75% |
| 31 Dec, 19 | 79 | - | 65,938,019 | 2.52% | 93.10% | 1.10% | 48 | 11.63% | 16 | -11.11% |
| 30 Sep, 19 | 79 | -12.22% | 64,315,367 | 4.94% | 91.95% | 0.50% | 43 | -24.56% | 18 | 38.46% |
| 30 Jun, 19 | 90 | 9.76% | 61,288,006 | 81.83% | 135.77% | 2.01% | 57 | 21.28% | 13 | -13.33% |
| 31 Mar, 19 | 82 | 18.84% | 33,706,180 | 6.31% | 82.15% | 1.38% | 47 | 88.00% | 15 | -46.43% |
| 31 Dec, 18 | 69 | -4.17% | 31,706,482 | -0.97% | 77.28% | 1.26% | 25 | -19.35% | 28 | 64.71% |
| 30 Sep, 18 | 72 | -8.86% | 32,016,953 | 0.54% | 78.46% | 1.28% | 31 | -6.06% | 17 | -26.09% |
| 30 Jun, 18 | 79 | -3.66% | 31,844,672 | -1.54% | 78.32% | 1.24% | 33 | - | 23 | -23.33% |
| 31 Mar, 18 | 82 | -6.82% | 32,343,677 | 0.72% | 79.61% | 1.27% | 33 | -23.26% | 30 | 25.00% |
| 31 Dec, 17 | 88 | 1.15% | 32,112,520 | 4.34% | 79.04% | 1.37% | 43 | -6.52% | 24 | 50.00% |
| 30 Sep, 17 | 87 | 12.99% | 30,777,746 | 1.93% | 76.01% | 1.36% | 46 | 21.05% | 16 | -27.27% |
| 30 Jun, 17 | 77 | -7.23% | 30,193,964 | -1.04% | 74.75% | 1.31% | 38 | - | 22 | -15.38% |
| 31 Mar, 17 | 83 | -10.75% | 30,512,593 | -1.92% | 75.59% | 1.27% | 38 | -19.15% | 26 | 30.00% |
| 31 Dec, 16 | 93 | -8.82% | 31,110,411 | -0.20% | 77.07% | 1.28% | 47 | -22.95% | 20 | 11.11% |
| 30 Sep, 16 | 102 | 6.25% | 31,171,920 | -1.11% | 77.47% | 1.22% | 61 | -11.59% | 18 | 28.57% |
| 30 Jun, 16 | 96 | 18.52% | 31,522,082 | 1.86% | 79.60% | 1.28% | 69 | 50.00% | 14 | -6.67% |
| 31 Mar, 16 | 81 | 9.46% | 30,947,154 | 5.67% | 78.97% | 1.41% | 46 | -8.00% | 15 | 15.38% |
| 31 Dec, 15 | 74 | 21.31% | 29,286,762 | 112.05% | 74.74% | 6.02% | 50 | 13.64% | 13 | 85.71% |
| 30 Sep, 15 | 61 | 35.56% | 13,811,499 | 21.35% | 35.25% | 4.18% | 44 | -2.22% | 7 | - |
| 30 Jun, 15 | 45 | - | 11,381,595 | - | 29.05% | - | 45 | - | - | - |
Seres Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Seres Therapeutics's stock was made by Young Teresa L. on Aug 06 2024, selling 24,480 shares at $1.08 per share (valued at $26.53K).
Seres Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 4 | 2 | 200.00% |
| Q2 2024 | 13 | 12 | 108.33% |
| Q1 2024 | 29 | 14 | 207.14% |
| Q4 2023 | 8 | 16 | 50.00% |
| Q2 2023 | 19 | 1 | 1900.00% |
| Q1 2023 | 18 | - | - |
| Q4 2022 | 2 | 1 | 200.00% |
| Q3 2022 | 13 | - | - |
| Q2 2022 | 17 | 1 | 1700.00% |
| Q1 2022 | 8 | - | - |
| Q2 2021 | 10 | 2 | 500.00% |
| Q1 2021 | 7 | - | - |
| Q4 2020 | 5 | 11 | 45.45% |
| Q2 2020 | 11 | - | - |
| Q1 2020 | 11 | 5 | 220.00% |
| Q4 2019 | 1 | 2 | 50.00% |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 10 | 6 | 166.67% |
| Q1 2019 | 8 | 6 | 133.33% |
| Q4 2018 | 2 | 4 | 50.00% |
4 total buy trades, and 2 total sell trades (buy/sell ratio of 2.00%) were made by Seres Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 6 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 8 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 3 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 1 | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | 2 | - |
| Q4 2018 | - | 3 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Seres Therapeutics's stocks.
MCRB Ownership FAQ
Who Owns Seres Therapeutics?
Seres Therapeutics is owned by institutional shareholders (47.27%), insiders (13.20%), and public (39.53%). The largest institutional shareholder of Seres Therapeutics is FLAGSHIP PIONEERING INC. (15.82% of total shares) and the top mutual fund owner is LORD ABBETT DEVELOPING GROWTH FUND, INC. (0.99% of total shares).
Who are the major institutional shareholders of Seres Therapeutics?
Seres Therapeutics's major institutional shareholders are FLAGSHIP PIONEERING INC., FMR LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 38.54% of the company's share outstanding.
How many Seres Therapeutics shareholders are there?
As of Jun 2024, there are 93 institutional shareholders of Seres Therapeutics.
What percentage of Seres Therapeutics is owned by FLAGSHIP PIONEERING INC?
FLAGSHIP PIONEERING INC owns 23.12M shares of Seres Therapeutics, representing 15.82% of the company's total shares outstanding, valued at $16.73M (as of Jun 2024).
What percentage of Seres Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 22.72M shares of Seres Therapeutics (MCRB), compromising 15.55% of the company, valued at $16.44M.
What percentage of Seres Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Seres Therapeutics. The company owns 6.29M of the company's shares outstanding (worth $4.55M).